EPO Patents = 4

Forward Citations = 3

Loading Chart...

8 inventors (with patents filed for the assignee):

Wojciech Sadowski (5 out of 5 patents)

Zbigniew Malota (5 out of 5 patents)

Kris Siemionow (4 out of 7 patents)

4. Marek Kraft (4 out of 8 patents)

5. Dominik Pieczynski (4 out of 6 patents)

6. Paul Lewicki (4 out of 6 patents)

7. Jacek Kania (4 out of 4 patents)

8. Michal Mikolajczak (1 out of 3 patents)

6 patents: Sort by Forward Citations

1. 12387337 - Autonomous segmentation of contrast filled coronary artery vessels on computed tomography images (2025-08-12),

2. 12067675 - Autonomous reconstruction of vessels on computed tomography images (2024-08-20),

3. 12051511 - Modelling blood vessels and blood flow (2024-07-30),

4. 11626211 - Modelling blood vessels and blood flow (2023-04-11),

5. 11521322 - Method and system for machine learning based segmentation of contrast filled coronary artery vessels on medical images (2022-12-06),

6. 11315293 - Autonomous segmentation of contrast filled coronary artery vessels on computed tomography images (2022-04-26),

Kardiolytics Inc. is a leading biotech company specializing in innovative solutions for cardiovascular diagnostics. Our state-of-the-art technology allows for early detection and monitoring of heart conditions, providing patients and healthcare professionals with valuable insights to improve heart health. With a focus on precision and accuracy, Kardiolytics is dedicated to advancing the field of cardiology through groundbreaking research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

6 Patents

#88 in Tulsa, OK

#224 in Oklahoma

#43,823 in US

Tulsa, OK, United States of America

Kardiolytics Inc.